Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective | SpringerLink
Role of pirfenidone in the management of pulmonary fibrosis | TCRM
A NEW ERA in IPF: Trials and Treatments - ppt download
Treatment | Idiopathic Pulmonary Fibrosis | Medthority.com
Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model - ScienceDirect
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation | Oncotarget
Frontiers | Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction | Cardiovascular Medicine
The multifaceted role of pirfenidone and its novel targets | Fibrogenesis & Tissue Repair | Full Text
Pirfenidone: an anti-fibrotic therapy for progressive kidney disease. - Abstract - Europe PMC
Biomedicines | Free Full-Text | Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease | HTML
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs) | Annals of the Rheumatic Diseases
Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways. | Semantic Scholar
Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease - Cellular and Molecular Gastroenterology and Hepatology
Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis - Hilberg - 2012 - The Clinical Respiratory Journal - Wiley Online Library
Proposed mechanism of action of nintedanib in idiopathic pulmonary... | Download Scientific Diagram
Reversion of in vivo fibrogenesis by novel chromone scaffolds - eBioMedicine
Potential mechanisms for the suppression of fibrogenesis by... | Download Scientific Diagram
Key interactors in the predicted mechanism of action of pirfenidone and... | Download Scientific Diagram
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Discovery of a small molecule having both potent anti-fibrotic and anti-inflammatory capabilities | bioRxiv
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence - ScienceDirect
Frontiers | Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction | Cardiovascular Medicine
Antifibrotic activities of pirfenidone in animal models | European Respiratory Society
